Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture.
With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. Our purpose is Science for a better life.
Headquartered in Leverkusen, Germany, the Bayer Group is a global enterprise with companies in 79 countries, including Pakistan.
Bayer in Pakistan
In Pakistan, Bayer operates as a private limited company under the name Bayer Pakistan (Pvt) Limited. The company was incorporated in 1963 and has been a major player in the healthcare and agriculture sectors of the country for the last 55 years.
Bayer in Pakistan is headquartered in the Southern port city of Karachi, the commercial and financial hub of Pakistan and home to a growing urban population of over 16 million people. Our geographical footprint spreads across the country, with production facilities in Karachi and Lahore and regional offices in almost all major cities.
We have over 700 passionate and innovative employees at Bayer in Pakistan, and remain committed to building a culture of innovation and inclusion where our employees are valued and enabled to do their best, day in and day out.
55 Years of Bayer in Pakistan
A glimpse at some of the major milestones of our five decades in Pakistan
1963 - Bayer Pakistan (Pvt.) Ltd. incorporated
1964 - Bayer factory site established at Karachi
1995 - Re-establishment of new manufacturing facilities at Karachi
2002 - Bayer group acquires business of Aventis Company, renamed Bayer Crop Science (Pvt) Ltd
2006 - Bayer AG acquires Schering AG and Medipharm (Pvt) Ltd comes under the management control of Bayer Pakistan
2013 - 50 years of Bayer in Pakistan
2018 - On June 7, 2018, Bayer becomes the sole owner of Monsanto Company worldwide, giving rise to a leading agriculture company with a high level of innovative strength, a strong product portfolio and the highest ethical standards.
What we do in Pakistan
Bayer’s operations in Pakistan encompass three divisions – Pharmaceuticals, Consumer Health and Crop Science – through which we work to contribute to providing solutions for a better life – be it with healthcare or agriculture.
The Pharmaceuticals division focuses on prescription products, including cardiology, women’s healthcare, oncology, hematology and ophthalmology. The division also comprises our radiology business.
The Consumer Health division markets mainly nonprescription (OTC = over-the-counter) products in the dermatology, nutritional supplement, analgesic, digestive health, cold, allergy, sinus and flu, foot care and sun protection categories.
The Crop Science division is a world-leading agriculture enterprise with businesses in seeds, crop protection and nonagricultural pest control. With the recent global acquisition of Monsanto by Bayer, our Crop Science division is in the process of being transformed with new exciting opportunities in agriculture: tending to the earth today and ensuring healthy food for all tomorrow.
Advancing Together: Our New Crop Science Division
There has never been a more important time for innovation in agriculture. Our world faces enormous challenges including a changing climate, limited natural resources, and a growing population. And we believe agriculture is part of the solution.
On June 7, 2018, Bayer became the sole owner of Monsanto Company worldwide. The acquisition of Monsanto gives rise to a leading agriculture company with a high level of innovative strength, a strong product portfolio and the highest ethical standards.
With this acquisition, we now have a new Crop Science Division that’s stronger and more equipped to handle the world’s agricultural challenges than ever.
We work to benefit not only the farmer, but also consumers and the ecosystem. Through the pillars of innovation, sustainability, and digital transformation we hope to balance the growing needs of humanity and the natural resources of our planet.
For more information on the Crop Science division, please visit:
For our complete product listing, please visit:
However, please note not all products are marketed in all countries.
Working on Behalf of a Better Life
At Bayer, we believe it is important to contribute to society’s future viability and create value in diverse ways. Within the scope of our social commitment, we make targeted strategic investments in the areas of science and education, health, social needs and community projects. This commitment is an integral element of Bayer’s corporate policy. In 2018, Bayer provided some 66 million euros to further these causes and support related activities. As with its business operations, Bayer’s social commitment is based on innovation and pioneering spirit.
In Pakistan, our Corporate Societal Engagement (CSE) initiatives focus primarily on health and education – two of the most pressing needs of any developing nation.
We partner with reputed organizations making a significant contribution in the health and education sectors in Pakistan, and support initiatives by them which improve access to quality of education and healthcare for under-served communities.
This way, we are able to invest in initiatives and projects that promote a gradual but sustainable improvement in standards of healthcare and education in Pakistan. After all, this is our purpose: Science for a better life.
TCF Aagahi Adult Literacy Program
Set up in 1996 by a group of concerned citizens, The Citizens Foundation (TCF) is one of the leading non-profit organizations operating in the education sector in Pakistan, providing low-cost formal education to the underserved, without discrimination
Aagahi means ‘creating awareness’ in the Urdu language. The Aagahi Adult Literacy Program run by TCF aims to impart non-formal literacy, numeracy and other basic skills to TCF students‘ mothers, sisters and other out-of-school women and girls between the ages of 12 and 65 years old. These literacy classes provide a two-fold benefit: improvement in TCF student performance by strengthening the home-school connection, and enhancing literacy in the community by enabling adult women to actively and independently contribute towards the running of their homes and communities.
In 2018, Bayer Pakistan has supported TCF by providing funding for the running of approximately 25% of Aagahi Adult Literacy Centers, reaching out to 18,000 women in rural and urban villages and slums across 68 cities and towns in Pakistan. Bayer Pakistan has partnered with TCF to support the Aagahi Adult Literacy Program since 2014.
Indus Hospital Expansion Project
The Indus Health Network provides absolutely free, quality treatment to millions of deserving patients through its countrywide network of hospitals in Pakistan. Indus Health Network is a respected and reputed player in the healthcare sector in Pakistan with a strong track record of running innovative and effective healthcare programs and interventions. It commenced operations in 2007 with one hospital in Karachi and has expanded over the years to include 12 full-service hospitals located in the large cities of Karachi and Lahore, as well as the towns of Badin, Bhong, Muzaffargarh and Multan. The Indus Health Network also has an extensive outreach program covering 41 districts of Pakistan for treatment of TB and Malaria.
The Indus Hospital is undertaking an expansion project of its Karachi-based hospital facility in order to facilitate the staggering rise in the number of patient visits and admission queues at the hospital on a daily basis. This expansion project includes the addition of rooms and beds in general wards, day surgery and ambulatory day centers in the departments of neurology, general medicine, pediatric oncology and surgery.
Bayer Pakistan has sponsored a consulting clinic in the expansion project to support the Indus Health Network to expand its network in order to make quality, free healthcare accessible to every Pakistani.
The Kidney Centre with Vital Diagnostic Equipment
With regard to kidney disease, Pakistan ranks eighth globally, with over 20 million people suffering from renal problems. The Kidney Centre (TKC) opened its doors to the public in 1985 with the aim of providing quality renal care to all, irrespective of their ability to pay.
While TKC started its operations with just two dialysis machines, today after a period of over 30 years, it is a modern medical facility – a 100-bed hospital equipped with a state-of-the-art dialysis unit that runs in four shifts with 66 dialysis machines plus eight executive dialysis cubicles. The hospital also has a general ward, semi-private and private rooms, four operating theatres, an ICU, laboratory, radiology and emergency services. In 2017, the Kidney Centre’s Patient Welfare expenditure exceeded PKR 329 million and 117,822 needy patients were treated.
In 2018, Bayer Pakistan has supported The Kidney Centre with funding for a stationary x-ray system with bucky stand and bucky table for its Radiology Department. The current x-ray machine had been in use for over 25 years and was in urgent need of an upgrade. In 2017, the radiology department carried out 24,275 procedures including x-rays, CT scans and ultrasounds, among which were 16,000 x-ray procedures.
AMTF in the fight against thalassemia
Afzaal Memorial Thalassemia Foundation (AMTF) provides leading edge, advanced personalized thalassemia care. AMTF is equipped with Pakistan’s first state of the art thalassemia Intensive Care Unit (ICU) with all required sub-specialties clinics, medical and diagnostics services for patients suffering from thalassemia. At AMTF, all patients are treated free of cost in line with the organization’s mission, and its vision to deliver the utmost level of passionate care and create mass awareness about childhood blood diseases.
Bayer has supported Afzaal Memorial Thalassemia Foundation (AMTF) with financial support for the purchase of life-saving medicines for the treatment of children suffering from thalassemia. Bayer has previously partnered with AMTF to support the treatment of thalassemia, as well as participating in blood donation camps.
Media and Communications Queries
Hafsa Zubair, Head of Communications and Public Affairs
Email: communicationspk .@bayer.com
At Bayer, we welcome and embrace creative and motivated talent to join a culture of innovation and inclusion.
Why Bayer? Because we’re a pioneer in the fields of human, animal, and plant health. Because we invent the solutions that will create a sustainable future for our planet. Because a career with Bayer means you can put your passion into practice and make an impact.